Data / Form D filings / SenGenix, Inc.
SenGenix, Inc.: Form D filings
SenGenix, Inc., a biotechnology company in Durham, NC, filed 5 Form D notices with the SEC between 2013 and 2017. The latest, on October 16, 2017, reports $6.3 million sold of a $6.3 million offering to 18 investors.
Find out what SenGenix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1738 HILLANDALE ROAD, Suite 102, Durham, NC, 27705
- Phone
- (919) 864-8693
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1586429
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2017 | New notice | $6,269,658 | $6,269,658 | $0 | 18 | Oct 2, 2017 | sec.gov |
| Sep 15, 2016 | New notice | $1,500,000 | $1,500,000 | $0 | 11 | Sep 1, 2016 | sec.gov |
| Oct 27, 2015 | New notice | $1,500,000 | $1,050,000 | $450,000 | 7 | Oct 13, 2015 | sec.gov |
| Jul 7, 2014 | Amendment | $2,500,000 | $1,969,801 | $530,199 | 15 | Aug 2, 2013 | sec.gov |
| Sep 13, 2013 | New notice | $1,500,000 | $450,000 | $1,050,000 | 3 | Aug 2, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard S. Surwit | Executive Officer, Director | |
| Homme E. Hellinga | Executive Officer, Director | |
| Lawrence S. Cohen | Director | |
| Ralph E. Snyderman | Director | |
| Sandra E. Cummings | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 16, 2017 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SenGenix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.